EnteroMedics, Inc. (ETRM) Posts Q1 Loss of 14c/Share

EnteroMedics, Inc. (NASDAQ: ETRM) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on EnteroMedics, Inc. (ETRM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c